Ethnomedicinally selected plants as sources of potential analgesic compounds: Indication of in vitro biological activity in receptor binding assays

Phytotherapy Research

Volumn 14, Issue 1, 2000, Pages 24-29

  Sampson, J H ^b   Phillipson, J D ^c   Bowery, N G ^c   O'Neill, M J ^a   Houston, J G ^a   Lewis, J A ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c NONE

Author keywords

Analgesia; Receptor ligand binding; Traditional medicine

Indexed keywords

BRADYKININ B2 RECEPTOR; CALCITONIN GENE RELATED PEPTIDE; CROTON EXTRACT; GINSENG EXTRACT; IPOMOEA PES CAPRAE EXTRACT; NEUROKININ 1 RECEPTOR; PLANT EXTRACT;

ANALGESIC ACTIVITY; ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; DRUG INHIBITION; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG SYNTHESIS; HERBAL MEDICINE; IN VITRO STUDY; LIGAND BINDING; NONHUMAN; PAIN; TRADITIONAL MEDICINE; TUMOR CELL LINE;

ANALGESICS, NON-NARCOTIC; ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CHO CELLS; CRICETINAE; HUMANS; PLANT EXTRACTS; PLANTS, MEDICINAL; RADIOLIGAND ASSAY; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; RECEPTORS, NEUROKININ-1; TUMOR CELLS, CULTURED;

AGERATUM CONYZOIDES; BARRINGTONIA; BARRINGTONIA EDULIS; CRICETINAE; CRICETULUS GRISEUS; CROTON TIGLIUM; IPOMEA; MAMMALIA; PANAX GINSENG; PHYSOSTIGMA VENENOSUM; SINOMENIUM ACUTUM; SOLIDAGO; SOLIDAGO VIRGAUREA; SYMPLOCOS; SYMPLOCOS LEPTOPHYLLA; TYPHONIUM GIGANTEUM;

EID: 0033980520     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1573(200002)14:1<24::AID-PTR537>3.0.CO;2-9     Document Type: Article

References (27)

1. Bohlin, L. (1983). Research on ethnopharmacologically active natural products at the Department of Pharmacognosy, Uppsala University. J. Ethnopharmacol. 38, 225-231.
2. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein dye binding. Anal. Biochem. 72, 248-254.
3. Cascieri, M. A., Ber, E., Fong, T. M. et al. (1992). Characterisation of the binding of a potent, selective radio-iodinated antagonist to the human neurokinin-1 receptor. Mol. Pharm. 42, 458-463.
4. Chang, H. and Butt, P. (1986 and 1987). Pharmacology and Applications of Chinese Materia Medica., Volumes I and II. World Scientific Publishing Co. Pte. Ltd, Singapore.
5. Christensen, B. V., and Reese, J. A. (1983). A study of the leaves Ipomea pes-caprae. Am. Pharm. Assoc. 27, 195-199.
6. Conn, P. (1991). Neuropeptide technology: Gene expression and neuropeptide receptors. Methods in Neuroscience, Academic Press, U.K.
7. Eggerickx, D., Raspe, E., Bertrand, D., Vassart, G., and Parmentier, M. (1992). Molecular cloning, functional expression and pharmacological characterisation of a human bradykinin BK II receptor gene. Biochem. Biophys. Res. Commun. 187, 1306-1313.
8. Farnsworth, N. R., and Morris, R. W. (1976). Higher plants: the sleeping giants of drug development. Am. J. Pharm. 148, 46-52.
9. Farnsworth, N. R. and Soejarto, D. D. (1985). Potential consequence for plant extinction in the United States on the current and future availability of prescription drugs. Econ. Bot. 39, 231-240.
10. Farnsworth, N. R. (1990). The role of ethnopharmacology in drug development. CIBA Foundation Symp 154, 231-240.
11. Gentry, A. H. (1993). Tropical forest diversity and the potential for new medicinal plants. In Human Medicinal Agents from Plants ed. by D. A. Kinghorn and M. F. Balandrin ACS Symposium Series No. 534, pp. 13-24. American Chemical Society, Washington DC.
12. Heuillet, E., Menager, J., Fardin, V. et al. (1993). Characterisation of a human NK 1 tachykinin receptor in the astrocytoma cell line U373MG. J. Neurochem. 60, 868-876.
13. Jung, M., Calassi, R., Maruani, J. et al. (1994). Neuropharmacological characterisation of SR-140333, a non peptide antagonist of NK 1 receptors. Neuropharmacology 33, 167-179.
14. Lee, C. M., Kum, W., Cockram, W. S., Teoh, R., and Young, J. D. (1989). Functional substance P receptors on a human astrocytoma cell line (U373MG). Brain Res. 488, 323-331.
15. Loomis, W. D., and Battaile, J. (1966). Plant phenolic compounds and the isolation of plant enzymes. Phytochemistry 5, 423-438.
16. Loub, W. B., Farnsworth, N. R., Soejarto, D. D., and Quinn, M. L. (1985) NAPRALERT: Computer handling of natural product research data. J. Chem. Info. Comput. Sci. 25, 99-103.
17. Morton, J. F. (1981). Atlas of Medicinal Plants of Middle America. Charles C. Thomas Publishing, Illinois, USA.
18. Moskowitz, M. A. (1990). Basic mechanisms of headache. Neurol. Clin. 8, 801-815.
19. Oliver-Bever, L. (1986). Medicinal Plants in Tropical West Africa. Cambridge University Press, Cambridge, UK.
20. O'Neill, M. J., and Lewis, J. A. (1993). The renaissance of plant research in the pharmaceutical industry. In Human Medicinal Agents from Plants, ed. by D. A. Kinghorn and M. F. Balandrin ACS Symposium Series No. 534, pp 48-55. American Chemical Society, Washington D.C.
21. Peigen, X. (1980). Traditional experience of Chinese herb medicine: Its application in drug research and new drug searching. Planta Med. 35, 1-94.
22. Pernow, B. (1983). Substance P. Neurol. Rev. 35, 35-141.
23. Plotkin, M. J., and Schultes, R. E. (1990). Virola: A promising genus for ethnopharmacological investigation. J. Psychoactive Drugs 22, 357-361.
24. Prance, G. (1991). What is ethnobotany today? J. Ethnopharmacol. 32, 209-216.
25. Sampson, J. H., Phillipson, J. D., Bowery, N. G. et al. (1994). Does ethnomedicinal selection for novel leads to analgesic agents confer any advantage? J. Pharm. Pharmacol. 46, S1061.
26. Steranka, L. R., Manning, D. C., Dehaas, C. J. et al. (1988). Bradykinin as a pain mediator: receptors are localised to sensory neurones and antagonists have analgesic actions. Proc. Natl. Acad. Sci. USA 85, 3245-3249.
27. Schultes, R. E. (1993). Plants in treating senile dementia in the Northwest Amazon. J. Ethnopharmacol. 38, 129-135.